Skip to content

Compounds · Heart, blood & kidney · Tissue repair and cardiovascular protection

TB-500 (Thymosin Beta-4) (and its active fragment Ac-SDKP)

On NovaEvumFull protocol

TB-500, Tβ4 fragment 17–23, Ac-LKKTETQ

A synthetic peptide fragment of Thymosin Beta-4, sold widely as a research chemical for injury recovery even though only the full-length protein has entered clinical trials for wound healing and cardiac repair. It promotes cell migration and blood-vessel growth but lacks formal human safety data and is banned in sports.

2–2.5 mg twice weekly, then weekly

Research score 60/100. Reference only, not a prescription.

  • Healing
  • Cardiovascular Health
  • Anti-inflammatory
  • Angiogenesis
  • Recovery Enhancement
  • Wound Healing
US status
Research Chemical
Approval
Research Chemical Only
Evidence
Full-length T-beta-4 has trials. TB-500 (fragment) has none.
Research score
60 / 100
Indication
Wound Healing (Research)
Origin
USA
Source category
Heart & Cardiovascular
Status group
Research chemical

Mechanism

Acts as a G-actin-sequestering protein regulating actin assembly and cell migration, raises VEGF and bFGF to spur blood-vessel growth and repair, and its active Ac-SDKP fragment blocks TGF-β signaling to limit heart fibrosis; also engages the ILK-PINCH-PARVA complex and PI3K/Akt pathway to protect heart cells under low-oxygen stress and aid stem-cell migration to injury sites.

Safety file

Full Thymosin Beta-4 is safe in trials, but this shorter form lacks human safety data; it is WADA-banned and carries a theoretical cancer risk.

  • Joint pain
  • Headache
  • Fatigue
  • Temporary hair growth at injection site

Reconstitution

Concentration by vial size and water volume
Vial2 mL water3 mL water
10 mg5 mg/mL3.33 mg/mL
  1. Use bacteriostatic water as the diluent.
  2. Add the water slowly, letting it run down the inside wall of the vial rather than onto the powder.
  3. Swirl gently to mix, then leave it to dissolve. Do not shake.
  4. Give it a few minutes. The finished solution should be clear and colourless.

Full mixing method

Protocol

Route: Subcutaneous

Standard protocol (subcutaneous)

  • Loading: 2 mg to 2.5 mg twice weekly (spaced 3 to 4 days apart, e.g. Monday and Thursday) for 4 to 6 weeks
  • Maintenance: 2 mg once weekly after the loading phase

Where it goes

  • TB-500 works systemically, so the injection site does not need to be near the injury
  • Rotate sites
  • Often run as the partner to BPC-157 in a healing stack

Dosing detail

  • Loading: about 2 to 2.5 mg twice weekly for 4 to 6 weeks.
  • Maintenance: about 2 mg once weekly thereafter.
  • Long half-life, so twice-weekly dosing is fine; site does not matter since it acts systemically.
  • TB-500 is on the WADA prohibited list and is banned in competitive sport.

Duration

  • Load for 4 to 6 weeks, then weekly maintenance. Common overall cycle is 8 to 12 weeks on, then a break.

Notes

  • The common partner to BPC-157 for recovery stacks.
  • Well tolerated by most.
  • Rotate injection sites.

Storage and handling

  • Keep the powdered (lyophilized) vial in a cool, dark place. Refrigerate it for longer-term storage before mixing.
  • Once reconstituted and refrigerated at 2–8 °C away from light, use the vial within 28 days.
  • Do not freeze a reconstituted vial, and keep it away from heat and sunlight.
  • If the solution turns cloudy, develops floating particles, or shows any other sign of degradation, stop using that vial.

Storage rules and when to discard

NovaEvum vial

Worksheet

2 mL bacteriostatic water into a 10 mg vial gives 5 mg/mL. A 2 mg draw is 40 units on a U-100 syringe.

Catalog fill
10 mg
Typical water
2 mL
Route
Subcutaneous
Cycle
4-week load, 4–6 week maintenance, then stop and reassess.
StepAmountFrequencyNotes
Loading2.0–2.5 mgTwice weekly40–50 units from a 2 mL reconstitution
Maintenance2.0 mgOnce weekly40 units
  • Amounts are milligrams, not micrograms — a 2 mg draw is eight times a 250 mcg BPC-157 draw.
  • Often paired with BPC-157 rather than run alone. See Wolverine Stack if both are in one vial.
  • Bacteriostatic water: 20–25 °C. Do not refrigerate the diluent.
  • Amounts on this sheet are reconstitution math for the vial, not a recommendation.